Nantahala Capital Management - CATALYST BIOSCIENCES INC ownership

CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 42 filers reported holding CATALYST BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of CATALYST BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$32,700
+37.2%
67,8000.0%0.00%
+50.0%
Q2 2023$23,838
-28.2%
67,800
-57.7%
0.00%
-33.3%
Q1 2023$33,209
-85.6%
160,430
-63.4%
0.00%
-80.0%
Q4 2022$231,074
-82.1%
438,055
-82.9%
0.02%
-81.9%
Q3 2022$1,288,000
-73.7%
2,554,735
-7.3%
0.08%
-66.3%
Q2 2022$4,906,000
+207.0%
2,755,903
+13.8%
0.25%
+246.5%
Q1 2022$1,598,000
-36.7%
2,420,789
-12.3%
0.07%
-20.2%
Q4 2021$2,524,000
-74.7%
2,761,660
+13.5%
0.09%
-71.7%
Q3 2021$9,996,000
-8.8%
2,432,212
-3.9%
0.32%
+1.3%
Q2 2021$10,961,000
-15.1%
2,531,360
-1.2%
0.31%
-17.5%
Q1 2021$12,909,000
+9.7%
2,561,334
+37.3%
0.38%
+3.3%
Q4 2020$11,770,000
+50.2%
1,865,334
+2.4%
0.36%
+52.1%
Q3 2020$7,834,000
-26.7%
1,821,7490.0%0.24%
-25.5%
Q2 2020$10,694,000
+69.2%
1,821,749
+25.9%
0.32%
+35.9%
Q1 2020$6,322,000
-13.4%
1,446,749
+35.0%
0.24%
+5.3%
Q4 2019$7,299,000
+39.9%
1,071,749
+0.8%
0.22%
+16.6%
Q3 2019$5,219,000
-32.1%
1,062,843
+1.9%
0.19%
-18.6%
Q2 2019$7,686,000
-1.1%
1,042,843
+8.8%
0.24%
-2.1%
Q1 2019$7,771,000
+15.2%
958,243
+12.0%
0.24%
+16.3%
Q4 2018$6,748,000855,2430.21%
Other shareholders
CATALYST BIOSCIENCES INC shareholders Q2 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 547,541$3,214,0006.22%
ACUTA CAPITAL PARTNERS, LLC 1,497,900$8,793,0002.54%
22NW, LP 735,841$4,319,0002.34%
Prosight Management, LP 248,050$1,456,0000.62%
Worth Venture Partners, LLC 127,983$751,0000.37%
Parkman Healthcare Partners LLC 215,237$1,263,0000.36%
Sio Capital Management, LLC 198,714$1,166,0000.34%
Amtrust Financial Services, Inc. 50,000$294,0000.32%
Nantahala Capital Management 1,821,749$10,694,0000.32%
Essex Woodlands Management, Inc. 78,622$462,0000.23%
View complete list of CATALYST BIOSCIENCES INC shareholders